semaglutide 2.4 Wegovy Weight Loss Treatment Set the dose selector to the correct dose (2.4 mg) WEGOVY(SEMAGLUTIDE) 2.4MG

Protein and fat typically trigger less severe symptoms

10.1111/dom.14765 43 KnopF

Dulaglutide, another synthetic GLP-1 agonist, offers once-weekly dosing via subcutaneous injection and carries similar efficacy to semaglutide but with a slightly different side-effect profile

Staying well-hydrated, eating light and balanced meals, and avoiding heavy or greasy foods may help reduce early side effects like nausea

Dose exposure was inferred from dispensing records, which may not reflect actual patient use

Current data from ongoing trials indicate that appropriate candidates for retatrutide generally include: Adults aged 18 or older with a BMI of 30 kg/m or greater